Relationship between osteopenia and clinical characteristics of parkinson's disease
- 1 January 1993
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 8 (4) , 507-511
- https://doi.org/10.1002/mds.870080416
Abstract
Pathological bone changes affect locomotor activity and may influence the outcome and prognosis of Parkinson's disease (PD). In this study, we determined the relationship between bone changes and PD. Bone study was performed by multiple scanning x‐ray photodensitometry (MD/MS) in 64 patients with PD and 42 age‐matched controls. We then compared the results with the clinical characteristics of PD. Osteopenia was detected in 22 (53.6%) of the 41 female and 6 (26%) of the 23 male patients, and in 6 (26%) of the 23 female and 2 (10.5%) of the 19 male controls. The frequency of osteopenia was significantly greater in the female patients than in the male patients or the female controls. Osteopenia was related to the duration of PD in the men, but not in the women. Twenty of 40 PD patients' hands showed side‐related differences in the analysis of both hands. In 19 of the 20 patients, the side of more severe osteopenia coincided with that of parkinsonian symptoms, suggesting that osteopenia is related to the pathophysiology of PD.Keywords
This publication has 9 references indexed in Scilit:
- Influence of Gonadal Steroids on Human and Monkey Cerebrospinal Fluid Homovanillie Acid ConcentrationsClinical Neuropharmacology, 1989
- Evidence of Estrogen Receptors in Normal Human Osteoblast-Like CellsScience, 1988
- Enhanced osteoblast proliferation and collagen gene expression by estradiol.Proceedings of the National Academy of Sciences, 1988
- Local and Systemic Factors in the Pathogenesis of OsteoporosisNew England Journal of Medicine, 1988
- Growth factors and the regulation of bone remodeling.Journal of Clinical Investigation, 1988
- Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin.Proceedings of the National Academy of Sciences, 1986
- Plasma growth hormone and insulin response to levodopa and amantadineJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1973
- SKELETAL CHANGES INDUCED BY DOPA DECARBOXYLASE INHIBITOR IN RATSThe Japanese Journal of Pharmacology, 1973
- ParkinsonismNeurology, 1967